TESSP-1 inhibitors represent a class of chemical compounds that are designed to interact with specific biological targets known as TESSP-1 proteins. The TESSP-1 designation typically refers to a particular protein structure or enzymatic function that these inhibitors aim to modulate through their action. These proteins may be implicated in a variety of biological pathways, and the inhibitors are crafted to bind with high specificity and affinity to the TESSP-1 sites. This binding process involves a series of intricate molecular interactions, often characterized by the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces between the inhibitor and the amino acid residues of the protein's active site or a regulatory motif.
The development of TESSP-1 inhibitors requires a deep understanding of the protein's structure and the conformational changes that occur upon ligand binding. Molecular biologists and chemists work together to elucidate the three-dimensional configuration of TESSP-1 proteins using techniques such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy. With this structural information, chemists can design small molecules that can fit into the protein's binding site with precision. The chemical synthesis of these inhibitors often involves complex organic reactions that allow for the introduction of specific functional groups at defined locations on the molecule. These functional groups are critical for the interaction with the protein and contribute to the inhibitor's selectivity, ensuring that it interacts primarily with the TESSP-1 protein and not with other unrelated proteins. The physicochemical properties of TESSP-1 inhibitors, such as solubility, stability, and overall molecular shape, are fine-tuned to optimize their interaction with the target protein, ensuring that they can effectively engage with the TESSP-1 sites without undesirable off-target effects.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A potent inhibitor of phosphoinositide 3-kinases (PI3K), LY294002 can reduce PI3K signaling, which may indirectly inhibit TESSP-1 due to the role of PI3K in cell survival and proliferation processes that could involve TESSP-1 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As a specific inhibitor of mitogen-activated protein kinase kinase (MEK), PD98059 disrupts the MEK/ERK pathway and could therefore indirectly inhibit TESSP-1 if its activity is modulated by ERK-mediated signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAP kinase inhibitor that interferes with stress-activated protein kinase pathways, potentially impacting TESSP-1 if it is regulated by p38 MAPK-dependent mechanisms. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), SP600125 could affect TESSP-1 activity by altering the JNK signaling pathway which may be involved in the cellular processes that TESSP-1 participates in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, affecting the MEK/ERK pathway, and could indirectly inhibit TESSP-1 if it is regulated by ERK signaling. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
As an inhibitor of PI3K, Wortmannin could indirectly inhibit TESSP-1 by reducing PI3K/Akt signaling which may be involved in the regulation of TESSP-1 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, Rapamycin could indirectly inhibit TESSP-1 by disrupting mTOR signaling pathways that might regulate TESSP-1 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a protein kinase C (PKC) inhibitor and could affect TESSP-1 activity if PKC signaling modulates TESSP-1. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
An NF-κB pathway inhibitor, BAY 11-7082 could potentially inhibit TESSP-1 if it is regulated by NF-κB signaling. | ||||||
ZM 336372 | 208260-29-1 | sc-202857 | 1 mg | $47.00 | 2 | |
A selective inhibitor of Raf kinase, ZM 336372 could affect TESSP-1 activity if it is regulated by the Raf/MEK/ERK signaling cascade. | ||||||